CorEvitas-IBD-600
This prospective, non-interventional research registry is designed to study the comparative effectiveness and comparative safety of approved treatments for IBD in a cohort of patients cared for by gastroenterologists across North America. Secondary…
- Investigator
- Angela Pham
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
RPC01-3204
This is an extension study to evaluate safety and efficacy of ozanimod in participants with moderately to severely active Crohn's Disease.
- Investigator
- Angela Pham
- Status
- Accepting Candidates
- Ages
- 18 Years - 75 Years
- Sexes
- All
RPC01-3203
This is a study to demonstrate the effect of oral ozanimod as maintenance therapy in participants with moderately to severely active Crohn's Disease.
- Investigator
- Angela Pham
- Status
- Accepting Candidates
- Ages
- 18 Years - 75 Years
- Sexes
- All